GlassScriptPhysician profile
John Matthew Thomas
NPI 1033471990
$2,916.17
in general payments reported to CMS, 2019-2025
12 companies · $64.55 in 2025
The $64.55 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $837 · 2021: $1,282 · 2022: $88.73 · 2024: $35.80 · 2025: $64.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,864.29 | 2020-2021 | |
| Smith+Nephew, INC. | $432.23 | 2019-2022 | |
| Stryker Corporation | $273.84 | 2019 | |
| Abbott Laboratories | $85.56 | 2019 | |
| Integra Lifesciences Corporation | $54.71 | 2020-2022 | |
| Mimedx Group, INC. | $47.41 | 2025 | |
| Hartmann USA, INC. | $44.56 | 2020-2022 | |
| Medtronic, INC. | $35.80 | 2024 | Intellis Adaptivestim |
| Medela LLC | $27.09 | 2021-2022 | |
| Kerecis Limited | $17.41 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.14 | 2025 | Nuzyra |
| Organogenesis INC. | $16.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.